Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Chemotherapy Effect
  • Retinoblastoma
Type
Interventional
Phase
Phase 3
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

To evaluate the effectiveness and complications of topotecan and melphalan for intraocular injection in retinoblastoma patients.

To evaluate the effectiveness and complications of topotecan and melphalan for intraocular injection in retinoblastoma patients.

Tracking Information

NCT #
NCT04799002
Collaborators
Not Provided
Investigators
Principal Investigator: Huashen Yang Sun Yat-sen University